Date: 2026-09-01 (updated 2026-10-23)
Source: ADSHG — https://www.addisonsdisease.org.uk/advocacy-campaign-better-adrenal-crisis-treatment
What happened?
After liquid hydrocortisone was discontinued, ADSHG launched an advocacy campaign for safer adrenal-crisis care. It highlights the risks of a powder-and-water process with more than ten steps during a life-threatening crisis, and calls for simpler emergency treatment plus more consistent A&E responses.
What is this about? (short)
Short term: licensing dual-chamber products such as Act-O-Vial® for adults with adrenal insufficiency in the UK. Longer term: pre-filled syringes or auto-injectors. The campaign also wants better adrenal-crisis awareness in emergency departments and consistent use of electronic patient-record alerts.
Campaign summary
ADSHG reports that more than 150 members wrote to MPs; briefing materials reached over 75 MPs, ministers and senior health officials; and parliamentary questions were raised in England, Scotland and Northern Ireland. Government statements indicate an Act-O-Vial licence application would be prioritised by the MHRA.
A parliamentary drop-in is planned at Westminster on 25 November 2026; the charity asks constituents to invite their MPs.
Who does this matter for?
People in the UK at risk of adrenal crisis, carers, and endocrine and emergency teams. Advocacy and licensing in Türkiye are separate; this summarises the UK campaign.
Access / country context
The campaign is backed by public-affairs support (DGA Group) and clinical/patient organisations including the Society for Endocrinology and the Royal College of Emergency Medicine. Product licences and NHS policy are UK-specific.
What it means for patients in Türkiye
This is not a Türkiye licensing or prescribing change. It shows that fast, easy emergency treatment and consistent crisis recognition in emergency care are patient-safety themes worldwide. Review your own emergency plan with your doctor.
Warning: This is a news summary, not dose or treatment advice. Ask your endocrinologist.
Medical disclaimer: Information on this site is prepared by a patient community for general awareness; for diagnosis, treatment or dose changes always consult your own doctor (endocrinologist). In an emergency call your local emergency number.